TRANSFORMING TODAY’S CANCER SURGERY WITH AR, MAKING THE INVISIBLE VISIBLE

Navari have developed a unique, patent-pending technology enabling intraoperative augmented reality (AR) guidance during minimally invasive procedures. With our technology, we enhance the ability of surgeons, setting new standards for today’s cancer treatment.

Todas as trocas de dados entre o Most Bet e os jogadores são criptografadas pela mais recente criptografia SSL nessa área.

Making minimally invasive surgery the first hand choice

We are dedicated towards shaping the future of cancer treatment through minimally invasive techniques like robotic- and laparoscopic surgery. Our mission is to broaden the availability of these advanced surgical methods, which are currently underutilized despite offering substantial clinical advantages over traditional open surgery. A key obstacle to their widespread adoption is the challenge of limited visualization during these procedures, which complicates precise navigation. We are committed to addressing this challenge by building a novel AR-tool, making these innovative and less invasive cancer treatments accessible to more patients.

Why minimally invasive surgery?

42% less risk1

Patients who undergo minimally invasive surgical procedures have a 42% lower risk of post-operative complications compared to those who undergo open surgery

3 days shorter hospital stay2

In average, patients undergoing minimally invasive surgery are discharged from the hospital after 4 days, compared to the 7-day average stay for open surgery.

Half the recovery time3

Patients who undergo minimally invasive procedures are 50% more likely to feel fully recovered after 12 months than those who undergo open surgery.

60% of all cancer patients undergo surgical intervention

Cancer is the second-leading cause of death, accounting for 10 million deaths and 18% of all fatalities worldwide. The incidence of cancer is expected to increase with more than 50% from 2020 to 2040. Consequently, cancer remains a significant and growing global health concern. Over the years, advancements in medical science have undoubtedly improved the prognosis and survival rates for many types of cancer. However, the rapid increase in cancer incidence places a significant burden on healthcare systems globally. There is a substantial need for new technologies and tools to meet this demand, as well as an increasing demand from patients for better and more safe procedures.

Najlepsze Wypłacalne Kasyna Online

Wybór najbardziej wypłacalnego kasyna online zależy od współczynnika wypłat i przewagi kasyna. Warto poznać zasady gier i korzystać z bonusów, aby zwiększyć swoje szanse na wygraną. Wypłacalne kasyna internetowe oferują różnorodne gry, szybkie wypłaty i różne metody płatności. Lista najlepiej wypłacalne kasyna online. Grając w takie kasyna, można cieszyć się uczciwą i bezpieczną rozrywką.

Latest news

REACH Incubator Program 2024

As participants in the REACH Incubator Program 2024 by Nordic Innovation House - Silicon Valley, co-founders Axel and Madeleine...

Navari recruits former co-founder of Surgical Science, David Löfstrand

Please join us in welcoming our new team member, David Löfstrand! David joined Navari in early January and...

Navari finishes first preclinical study, reaching PoC in vivo

During the last few months, Navari has been planning, designing, and coordinating activities related to their first preclinical study.

Navari awarded for Women TechEU grant

Navari is thrilled to share that they have been selected as one of the companies who have been granted funding under...

Navari is awarded two grants from Vinnova

This autumn, Navari has been awarded not only one, but two grants from Vinnova.

Navari has closed a pre-seed investment of 7.5 million SEK

Deep tech company Navari has raised a total of SEK 7.5 million to continue developing an AR-based technology for keyhole surgery.